Home › Who we are › The Company

The Company

Synexus’ origins date back to 1992, when Dr Ian Smith (presently Medical Director), then a practising GP, bought the house next door to his surgery to provide a dedicated clinical trials centre - the first of its kind in the world. This became the Edgebright Partnership. Synexus was formed in 1998 following the merger of Edgebright and the clinical trials division of AEA Technology plc.

Ownership

In 2005, Synexus was listed on the London Stock Exchange's AIM
In 2007, following the acceptance of a cash offer, Synexus was taken private by Lyceum Capital.

Synexus is now financed through a combination of private equity from Lyceum and management equity. The new financial structure, and continuing investment by Lyceum has allowed the company to continue its global expansion and to operate across a broader range of therapeutic areas.

Click here to link to Lyceum Capital

Latest Developments

At the beginning of 2010 Synexus acquired ClinPharm which increased the number of Synexus' DRCs to 26 in nine countries, thus significantly strengthening its European reach and further reinforcing its position as a global leader.

Back to top ^

Synexus Limited, Registered in England and Wales, Registered number 3724238, Registered Office: Sandringham House, Ackhurst Park, Chorley , Lancashire, PR7 1NY

Strength in numbers

The Company

Ownership

Latest Developments

Regulatory

Patient

Therapy